Hospital
Hospital Service Dist. No. 1 of the Parish of ST. Charles, State of LA
Hospital Service Dist. No. 1 of the Parish of ST. Charles, State of LA was paid $13.85M by Medicaid between Jan 2018 and Dec 2024, across 101 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoHOSPITAL SERVICE DIST. NO. 1 OF THE PARISH OF ST. CHARLES, STATE OF LA
LULING, LA 70070
LULING, LA 70070
33aNPI1295716637assigned 11/11/2005
33bProvider typePsychiatric Hospital Unit
28Total paid$13.85M
24GClaims126,688
24DCodes billed101
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in Louisiana
Rank by total paid#2 of 7
Median peer was paid$3.63M
This provider vs. median3.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,757 | $1.49M | |
| 2019 | 12,636 | $1.27M | |
| 2020 | 10,349 | $1.10M | |
| 2021 | 19,923 | $1.96M | |
| 2022 | 24,795 | $2.41M | |
| 2023 | 26,326 | $3.29M | |
| 2024incomplete | 16,902 | $2.34M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 14,855 | 13,656 | $3.22M |
| A0427 | Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | 18% | 6,323 | 5,194 | $2.50M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 13,517 | 12,600 | $2.41M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.7% | 2,981 | 2,713 | $1.21M |
| A0425 | Ground mileage, per statute mile | 8.7% | 11,138 | 8,471 | $1.20M |
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 5.4% | 3,353 | 2,749 | $748K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.1% | 1,157 | 1,046 | $424K |
| 73630 | 2.3% | 2,070 | 1,901 | $319K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.6% | 3,520 | 3,077 | $215K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 2,308 | 1,843 | $191K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 5,091 | 4,377 | $179K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 3,335 | 2,885 | $159K |
89 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,025 | $114K |
| 73564 | <1% | 558 | $91K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,529 | $89K |
| 74019 | <1% | 581 | $79K | |
| 80053 | Comprehensive metabolic panel | <1% | 8,257 | $65K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 2,197 | $57K |
| G0378 | Hospital observation service, per hour | <1% | 90 | $56K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,146 | $51K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,992 | $50K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 774 | $46K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 123 | $44K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,666 | $32K |
| 81025 | <1% | 4,887 | $31K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 944 | $28K |
| 71045 | Radiologic examination, chest; single view | <1% | 566 | $28K |
| 73610 | <1% | 279 | $28K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 60 | $22K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 112 | $20K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 266 | $15K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 26 | $14K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 493 | $13K |
| 73130 | <1% | 161 | $13K | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 196 | $9K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 51 | $8K |
| 81000 | <1% | 2,613 | $7K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 31 | $7K |
| 87400 | <1% | 464 | $6K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,687 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 105 | $6K |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 32 | $5K |
| 73030 | <1% | 41 | $3K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 640 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 13 | $3K |
| 94761 | <1% | 33 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 19 | $2K |
| C1769 | Guide wire | <1% | 18 | $2K |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | <1% | 18 | $2K |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 17 | $2K |
| 73562 | <1% | 12 | $1K | |
| 83690 | <1% | 259 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 167 | $1K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 32 | $1K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 46 | $980.15 |
| 86235 | <1% | 37 | $859.17 | |
| 84484 | <1% | 94 | $812.77 | |
| 81003 | <1% | 422 | $705.69 | |
| 83735 | <1% | 176 | $641.44 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 18 | $632.69 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $628.84 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 77 | $616.05 |
| J2704 | Injection, propofol, 10 mg | <1% | 3,995 | $562.47 |
| 99152 | <1% | 32 | $466.78 | |
| 80061 | Lipid panel | <1% | 52 | $427.08 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 18 | $405.27 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,709 | $384.59 |
| 82728 | <1% | 28 | $288.28 | |
| 84466 | <1% | 28 | $269.86 | |
| 83970 | <1% | 12 | $207.64 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 29 | $169.33 |
| 82962 | <1% | 96 | $161.07 | |
| 83540 | <1% | 28 | $136.82 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 12 | $128.70 |
| 82550 | <1% | 29 | $125.72 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 25 | $120.36 |
| 86200 | <1% | 13 | $116.55 | |
| 84100 | <1% | 53 | $114.18 | |
| 86140 | <1% | 30 | $110.82 | |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | <1% | 99 | $103.56 |
| 85651 | <1% | 31 | $95.62 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 305 | $89.24 |
| 88342 | <1% | 249 | $69.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,759 | $65.03 |
| 82570 | <1% | 30 | $62.64 | |
| 86850 | <1% | 22 | $47.37 | |
| 84156 | <1% | 30 | $44.37 | |
| 85610 | <1% | 18 | $40.75 | |
| 86901 | <1% | 22 | $35.02 | |
| 86900 | <1% | 22 | $35.02 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 35 | $30.81 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 253 | $14.94 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 319 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 57 | $0.00 |
| 00813 | 0% | 415 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 32 | $0.00 |
| 00811 | 0% | 351 | $0.00 | |
| 00731 | 0% | 616 | $0.00 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 0% | 75 | $0.00 |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg | 0% | 24 | $0.00 |
| 00812 | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialREEDER, AUSTIN (CEO)
| Provider | Location | Paid |
|---|---|---|
| Froedtert Memorial Lutheran Hospital, INC. | Milwaukee, WI | $157.85M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.